ATRA - Atara Biotherapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - ATRA (1604464)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S18+0-2+12+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2018-10-04
ATRACiechanover Isaac E.CEOS - Sale$40.22-7,800784,163-1%-$313,753
D
2018-10-01
ATRANewell JoeChief Tech. Operations OfficerS - Sale+OE$41.28-1,50031,858-4%-$61,918
2018-09-26
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$43.08-13,500306,355-4%-$581,580
M
2018-09-24
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$40.17-31,500319,855-9%-$1,265,330
M
2018-09-18
ATRACiechanover Isaac E.CEOS - Sale$39.80-7,800871,291-1%-$310,479
2018-07-27
ATRAKoppikar UtpalCFOP - Purchase$36.80+2,00047,000+4%+$73,600
M
2018-09-06
ATRACiechanover Isaac E.CEOS - Sale$39.35-7,800879,091-1%-$306,923
D
2018-09-04
ATRANewell JoeChief Tech. Operations OfficerS - Sale+OE$39.45-1,50031,858-4%-$59,178
M
2018-08-20
ATRACiechanover Isaac E.CEOS - Sale$36.37-7,800886,891-1%-$283,647
2018-08-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$37.54-775351,3550%-$29,094
M
2018-08-06
ATRACiechanover Isaac E.CEOS - Sale$37.43-7,800894,691-1%-$291,957
D
2018-08-01
ATRANewell JoeChief Tech. Operations OfficerS - Sale+OE$37.74-1,50031,858-4%-$56,610
D
2018-07-30
ATRANewell JoeChief Tech. Operations OfficerS - Sale+OE$35.78-10,00031,858-24%-$357,787
M
2018-07-26
ATRACiechanover Isaac E.CEOS - Sale$38.00-7,800902,491-1%-$296,432
M
2018-07-09
ATRACiechanover Isaac E.CEOS - Sale$40.00-58,400910,291-6%-$2,335,739
M
2018-06-26
ATRACiechanover Isaac E.CEOS - Sale$39.60-6,400968,691-1%-$253,425
2018-06-18
ATRAGallagher Carol GiltnerDirS - Sale$44.78-2,500110,192-2%-$111,944
M
2018-06-05
ATRACiechanover Isaac E.CEOS - Sale$48.56-8,800975,091-1%-$427,288
M
2018-05-21
ATRACiechanover Isaac E.CEOS - Sale$51.74-8,800983,891-1%-$455,313
2018-05-18
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale$50.03-25,860107,972-19%-$1,293,776
D
2018-05-15
ATRAPorter DerrellSVP, Head of Global CommercialS - Sale+OE$45.02-16,33412,500-57%-$735,357
D
2018-05-14
ATRAFust Matthew KDirS - Sale+OE$43.57-12,28620,354-38%-$535,301
D
2018-05-16
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$46.06-4,647133,832-3%-$214,026
D
2018-05-16
ATRAGallagher Carol GiltnerDirS - Sale+OE$46.06-273111,1920%-$12,574
D
2018-05-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$45.30-25,775352,130-7%-$1,167,480
M
2018-05-09
ATRACiechanover Isaac E.CEOS - Sale$39.85-8,800992,691-1%-$350,637
2018-05-08
ATRAPorter DerrellSVP, Head of Global CommercialS - Sale$40.15-1,54412,500-11%-$61,992
M
2018-04-26
ATRACiechanover Isaac E.CEOS - Sale$42.46-8,8001,001,491-1%-$373,659
M
2018-04-11
ATRACiechanover Isaac E.CEOS - Sale$41.87-8,8001,010,291-1%-$368,472
A
2018-03-27
ATRACiechanover Isaac E.CEOS - Sale$38.40-200206,4780%-$7,680
2018-03-29
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale$40.07-22,400133,671-14%-$897,568
D
2018-03-27
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$37.87-100,203156,071-39%-$3,795,062
M
2018-03-26
ATRACiechanover Isaac E.CEOS - Sale$38.59-8,8001,225,769-1%-$339,549
2018-03-26
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$39.79-18,327352,905-5%-$729,265
M
2018-03-19
ATRAMcGrath JohnEVP, CFOS - Sale$40.41-6,00088,762-6%-$242,460
M
2018-03-15
ATRACiechanover Isaac E.CEOS - Sale$42.13-8,8001,027,891-1%-$370,748
2018-03-12
ATRACiechanover Isaac E.CEOS - Sale$46.31-1,0001,036,6910%-$46,314
M
2018-02-20
ATRACiechanover Isaac E.CEOS - Sale$44.65-17,8001,037,691-2%-$794,733
D
2018-02-16
ATRAGallagher Carol GiltnerDirS - Sale+OE$46.50-1,183110,920-1%-$55,010
DM
2018-02-15
ATRAMcGrath JohnEVP, CFOS - Sale+OE$47.07-13,00094,762-12%-$611,925
DM
2018-02-15
ATRACiechanover Isaac E.CEOS - Sale+OE$46.92-20,0001,055,491-2%-$938,459
M
2018-02-13
ATRACiechanover Isaac E.CEOS - Sale$46.80-20,0001,071,553-2%-$935,956
2018-02-09
ATRATurner Heather DFormer EVP, GC, Sec.S - Sale$38.01-12,21469,494-15%-$464,210
M
2018-02-08
ATRACiechanover Isaac E.CEOS - Sale$37.44-8,8001,091,553-1%-$329,429
M
2018-01-25
ATRACiechanover Isaac E.CEOS - Sale$35.26-19,3001,035,353-2%-$680,534
M
2018-01-22
ATRACiechanover Isaac E.CEOS - Sale$34.58-48,5001,404,131-3%-$1,677,279
2018-01-16
ATRACiechanover Isaac E.CEOS - Sale$30.38-6001,103,1530%-$18,228
DM
2018-01-11
ATRAMcGrath JohnEVP, CFOS - Sale+OE$24.35-37,00089,654-29%-$900,815
M
2018-01-10
ATRACiechanover Isaac E.CEOS - Sale$21.39-28,7001,103,753-3%-$613,843
2017-12-29
ATRAMcGrath JohnEVP, CFOS - Sale$20.00-32,00096,654-25%-$640,000
M
2017-12-28
ATRACiechanover Isaac E.CEOS - Sale$18.29-22,2001,132,453-2%-$405,958
M
2017-12-12
ATRACiechanover Isaac E.CEOS - Sale$14.64-4,4001,154,6530%-$64,438
M
2017-11-29
ATRACiechanover Isaac E.CEOS - Sale$14.24-4,4001,159,0530%-$62,678
D
2017-11-17
ATRASoffer GadEVP, Chief Strategy OfficerS - Sale+OE$15.00-7,000256,236-3%-$105,000
D
2017-11-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$13.36-1,604362,5300%-$21,429
D
2017-11-16
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$14.20-3,290163,052-2%-$46,718
D
2017-11-16
ATRAGallagher Carol GiltnerDirS - Sale+OE$14.20-1,184109,738-1%-$16,813
M
2017-11-13
ATRACiechanover Isaac E.CEOS - Sale$13.47-4,4001,157,5450%-$59,268
M
2017-10-26
ATRACiechanover Isaac E.CEOS - Sale$13.59-4,4001,161,9450%-$59,774
2017-10-16
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$14.35-6,000363,305-2%-$86,100
M
2017-10-11
ATRACiechanover Isaac E.CEOS - Sale$15.02-4,4001,166,3450%-$66,066
M
2017-09-19
ATRACiechanover Isaac E.CEOS - Sale$15.54-4,4001,170,7450%-$68,354
2017-09-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$15.30-6,000369,305-2%-$91,800
M
2017-09-06
ATRACiechanover Isaac E.CEOS - Sale$15.02-4,4001,175,1450%-$66,066
M
2017-08-22
ATRACiechanover Isaac E.CEOS - Sale$13.54-4,4001,179,5450%-$59,554
D
2017-08-16
ATRAGallagher Carol GiltnerDirS - Sale+OE$14.30-1,184108,556-1%-$16,931
DM
2017-08-15
ATRASoffer GadEVP, Chief Strategy OfficerS - Sale+OE$14.88-9,464259,090-4%-$140,802
DM
2017-08-15
ATRAMcGrath JohnEVP, CFOS - Sale+OE$14.31-4,200120,957-3%-$60,102
D
2017-08-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$14.75-7,604375,305-2%-$112,159
D
2017-08-16
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$14.33-3,021159,130-2%-$43,291
M
2017-08-10
ATRACiechanover Isaac E.CEOS - Sale$14.66-4,4001,178,0370%-$64,526
M
2017-07-24
ATRACiechanover Isaac E.CEOS - Sale$16.49-5,5001,182,4370%-$90,704
2017-07-17
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$14.92-6,000382,080-2%-$89,520
2017-06-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$12.65-6,000388,080-2%-$75,900
D
2017-06-09
ATRAGallagher Carol GiltnerDirS - Sale+OE$13.15-1,000107,374-1%-$13,150
M
2017-05-30
ATRACiechanover Isaac E.CEOS - Sale$13.35-6,9001,187,937-1%-$92,115
M
2017-05-17
ATRACiechanover Isaac E.CEOS - Sale$14.91-4,8001,194,8370%-$71,568
DM
2017-05-15
ATRAMcGrath JohnEVP, CFOS - Sale+OE$15.11-4,000117,460-3%-$60,440
D
2017-05-16
ATRAGallagher Carol GiltnerDirS - Sale+OE$15.25-1,184103,374-1%-$18,056
D
2017-05-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$14.99-7,604394,080-2%-$113,984
D
2017-05-16
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$15.25-3,873153,000-2%-$59,063
DM
2017-05-15
ATRASoffer GadEVP, Chief Strategy OfficerS - Sale+OE$15.16-12,674264,409-5%-$192,098
M
2017-04-25
ATRACiechanover Isaac E.CEOS - Sale$17.56-7,2001,193,729-1%-$126,405-3-7
2017-04-17
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$17.28-6,000400,855-1%-$103,680+2-5
M
2017-04-10
ATRACiechanover Isaac E.CEOS - Sale$17.03-7,2001,200,929-1%-$122,598-1+6-13
M
2017-03-27
ATRACiechanover Isaac E.CEOS - Sale$20.06-16,0001,208,129-1%-$320,944+3+9-3
M
2017-03-22
ATRAMcGrath JohnEVP, CFOS - Sale$20.65-14,000112,827-11%-$289,045-1-9-19
M
2017-03-16
ATRACiechanover Isaac E.CEOS - Sale$19.38-30,8001,224,129-2%-$596,808-5-3-15
2017-03-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$19.60-6,000406,855-1%-$117,600+6+5-13
2017-03-10
ATRASoffer GadEVP, Chief Strategy OfficerS - Sale$20.00-2,500266,527-1%-$50,000-11-13-28
2017-03-10
ATRAMcGrath JohnEVP, CFOS - Sale$20.00-24,000126,827-16%-$480,000+8-12-21
2017-02-21
ATRAMcGrath JohnEVP, CFOS - Sale$15.14-9,000150,827-6%-$136,260-1+4+42
D
2017-02-16
ATRAGallagher Carol GiltnerDirS - Sale+OE$16.10-1,183102,192-1%-$19,0460-5+28
DM
2017-02-14
ATRASoffer GadEVP, Chief Strategy OfficerS - Sale+OE$15.42-14,273269,027-5%-$220,1440-5+28
D
2017-02-16
ATRAClark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$15.96-3,059149,661-2%-$48,8220-5+28
D
2017-02-15
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$15.49-7,604412,855-2%-$117,7860-5+28
DM
2017-02-15
ATRACiechanover Isaac E.CEOS - Sale+OE$15.55-4,8001,254,9290%-$74,6640-5+28
2017-02-10
ATRASoffer GadEVP, Chief Strategy OfficerS - Sale$15.47-6,274269,538-2%-$97,029+4+3+34
2017-02-09
ATRAHaqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$15.46-13,975419,630-3%-$216,054+1+3+48
2017-02-09
ATRATurner Heather DEVP, GC, Sec.S - Sale$15.72-12,21586,142-12%-$192,067+1+3+48
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top